Paid clinical trials are listed on several free, searchable databases, and most healthy-volunteer studies compensate participants between $150 and $13,000 depending on what’s involved. The key is knowing where to look, what the listings actually mean, and how to tell a legitimate opportunity from a waste of your time.
Where to Search for Paid Trials
The most comprehensive starting point is ClinicalTrials.gov, the U.S. government registry where researchers are required to list most studies. You can filter by condition, location, age, and sex. Not every listing spells out payment in the description, but studies recruiting “healthy volunteers” almost always offer compensation. Look for language like “stipend,” “compensation,” or “reimbursement” in the study details.
Beyond the federal registry, several other resources are worth checking:
- Research facility websites. Major academic medical centers and dedicated research units (like Covance, PPD, or Parexel) post their own paid studies with specific dollar amounts, which ClinicalTrials.gov listings often omit.
- ResearchMatch.org. A nonprofit tool funded by the National Institutes of Health that matches volunteers with studies at academic institutions across the country.
- Local university hospitals. Most have research recruitment pages listing active studies. Search “[your city] clinical research volunteer” to find them.
- Recruitment platforms. Sites like Recruit.me or StudyPages aggregate trials and let you create a profile so researchers can reach out to you directly.
When you find a listing, look for the study’s NCT number, a unique identifier that starts with “NCT” followed by digits. Every legitimate trial registered with the federal government has one. If a study advertises payment but has no NCT number and no mention of ethics board approval, that’s a reason to be cautious.
How Much Paid Trials Actually Pay
Compensation varies enormously based on what the study asks of you. A simple vaccine study with no overnight stay might pay $150. A Phase 1 trial requiring 34 consecutive days and nights confined to a research clinic has paid as much as $13,000. The median trial length across Phase 1 studies is about 20 days, with a median confinement of nine nights.
The general pattern is straightforward: the more time, discomfort, or inconvenience involved, the higher the payment. Overnight inpatient stays pay more than outpatient visits. Studies requiring multiple blood draws, dietary restrictions, or washout periods (where you stop taking certain medications beforehand) tend to pay more than studies that only need a questionnaire and a single visit. Short outpatient studies for things like surveys or wearable device testing might pay $50 to $300, while multi-week inpatient stays routinely offer several thousand dollars.
Payment is typically structured in installments tied to each visit or study milestone rather than as a single lump sum. This means you’ll usually receive partial payment if you complete part of the study but not all of it. Ask about the payment schedule before you enroll so you know exactly when and how you’ll be paid.
What Makes You Eligible
Every trial has specific eligibility criteria, and these are the biggest factor determining which studies you can actually join. Healthy-volunteer studies, common in early-phase drug testing, typically require that you have no major medical conditions, take no regular medications, fall within a certain age range, and meet BMI requirements. Some require you to be a nonsmoker or to abstain from alcohol during the study.
If you do have a medical condition, that can open a different set of trials. Studies testing new treatments for diabetes, arthritis, depression, or cancer actively seek people who have those conditions. These studies may or may not offer direct payment, but they often provide the experimental treatment at no cost, cover all medical visits, and reimburse travel expenses.
Eligibility screening usually happens in two stages. First, you’ll complete a phone or online pre-screening questionnaire. If you pass that, you’ll be invited for an in-person screening visit that includes bloodwork, a physical exam, and sometimes an EKG or other tests. This screening visit itself is often compensated, even if you don’t end up qualifying for the full study.
Travel Costs and Reimbursement
The FDA draws a clear distinction between payment for your participation and reimbursement for your expenses. Travel costs like airfare, parking, gas mileage, and lodging are reimbursed separately and are not considered part of your compensation. This means they don’t factor into the ethical review of whether payment is “too high,” and many studies are generous with travel support specifically because regulators encourage removing financial barriers to participation.
Some trials, particularly large multi-site studies, will arrange and pay for travel directly. Others reimburse you after you submit receipts. If a study interests you but the site is far away, ask the research coordinator about their travel policy before ruling it out. Many studies budget specifically for participants who need to fly in.
Taxes on Clinical Trial Payments
Clinical trial payments are taxable income. If a single institution pays you more than $599 in a calendar year, it is required to report that amount to the IRS and send you a Form 1099. Reimbursements for actual expenses like parking or travel don’t count toward that threshold.
If your total payments stay at $200 or less per year from one institution, some research sites won’t even collect your Social Security number. But the income is still technically taxable regardless of whether you receive a 1099. If you participate in multiple studies across different sites, each institution tracks its own $599 reporting threshold independently, so keep your own records of what you’ve earned across all of them.
How Ethics Boards Protect You
Before any clinical trial can recruit participants, it must be approved by an Institutional Review Board, or IRB. This independent committee reviews the study’s risks, procedures, and yes, the payment structure. Federal regulations require IRBs to confirm that a study has a favorable balance between its risks and its potential scientific value, and they must make that determination without counting your payment as a “benefit” that offsets risk.
There’s a persistent concern in research ethics about whether high payments might cloud someone’s judgment, pushing them to accept risks they otherwise wouldn’t. In practice, the ethical framework works like this: if the IRB has already determined that participating is reasonable for someone in the target population, then the payment amount itself isn’t the problem. The study either has acceptable risks or it doesn’t, regardless of what participants are paid. This means you shouldn’t interpret a high payment as a sign that a study is dangerous. It usually reflects the time commitment and inconvenience, not the level of medical risk.
Red Flags to Watch For
Legitimate clinical trials never ask you to pay to participate. If a study requires you to cover the cost of a drug, a screening test, or an enrollment fee, walk away. Real trials are funded by pharmaceutical companies, government agencies, or academic institutions, and those sponsors cover all research-related costs.
Other warning signs include studies with no identifiable research institution or principal investigator, vague descriptions of what the study involves, pressure to enroll immediately without time to review the informed consent document, and promises of guaranteed cures. Every legitimate trial will give you a detailed informed consent form that explains exactly what will happen, what the risks are, and how you can withdraw at any time without penalty. You should have days, not minutes, to review it.
If a study is listed on ClinicalTrials.gov with a valid NCT number, names a recognized institution as the sponsor, and has clearly stated IRB approval, those are strong signs you’re looking at a real opportunity. When in doubt, call the research site directly using a phone number you find on the institution’s official website, not from the ad itself.